Menu

Tobacco

Today, tobacco is the only legal substance that, when used as intended, kills 6.3 million people per year. Tobacco is responsible for about one in five deaths annually, and a major contributor to the global pandemic of non-communicable diseases. PHI applies its expertise in the economics of tobacco control to advance policies to reduce smoking and vaping in various countries around the world. We also specialize in evaluating new approaches to prevention and treatment; building capacity by training the next generation of top-notch investigators in tobacco control research; and providing technical assistance to health care providers and institutions, policy makers, health departments, ministries, and community advocates working to reduce rates of smoking. PHI has experience working with private attorneys, government agencies and public health organizations to use litigation settlement funds to improve public health, including tobacco cases.

Our expertise can make your work stronger

See how PHI can work with you to support or lead your work on this issue.

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org